Literature DB >> 21357536

Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.

Anthony J St Leger1, Bjoern Peters, John Sidney, Alessandro Sette, Robert L Hendricks.   

Abstract

HSV type 1 (HSV-1) expresses its genes sequentially as immediate early (α), early (β), leaky late (γ1), and true late (γ2), where viral DNA synthesis is an absolute prerequisite only for γ2 gene expression. The γ1 protein glycoprotein B (gB) contains a strongly immunodominant CD8(+) T cell epitope (gB(498-505)) that is recognized by 50% of both the CD8(+) effector T cells in acutely infected trigeminal ganglia (TG) and the CD8(+) memory T cells in latently infected TG. Of 376 predicted HSV-1 CD8(+) T cell epitopes in C57BL/6 mice, 19 (gB(498-505) and 18 subdominant epitopes) stimulated CD8(+) T cells in the spleens and TG of HSV-1 acutely infected mice. These 19 epitopes identified virtually all CD8(+) T cells in the infected TG that represent all or the vast majority of the HSV-specific CD8(+) TCR repertoire. Only 11 of ∼84 HSV-1 proteins are recognized by CD8(+) T cells, and most (∼80%) are expressed before viral DNA synthesis. Neither the immunodominance of gB(498-505) nor the dominance hierarchy of the subdominant epitopes is due solely to MHC or TCR affinity. We conclude that the vast majority of CD8(+) T cells in HSV-1 acutely infected TG are HSV specific, that HSV-1 β and γ1 proteins that are expressed before viral DNA synthesis are favored targets of CD8(+) T cells, and that dominance within the TCR repertoire is likely due to the frequency or expansion and survival characteristics of CD8(+) T cell precursors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357536      PMCID: PMC3308013          DOI: 10.4049/jimmunol.1003735

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.

Authors:  Guy de Bruyn; Mauricio Vargas-Cortez; Terri Warren; Stephen K Tyring; Kenneth H Fife; Jacob Lalezari; Rebecca C Brady; Mohsen Shahmanesh; George Kinghorn; Karl R Beutner; Rajul Patel; Margaret A Drehobl; Patrick Horner; Terrance O Kurtz; Sharon McDermott; Anna Wald; Lawrence Corey
Journal:  Vaccine       Date:  2005-09-21       Impact factor: 3.641

2.  The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

Authors:  M E Wallace; R Keating; W R Heath; F R Carbone
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.

Authors:  Vilma Decman; Paul R Kinchington; Stephen A K Harvey; Robert L Hendricks
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.

Authors:  Nancy Hosken; Patrick McGowan; Amalia Meier; David M Koelle; Paul Sleath; Felecia Wagener; Mark Elliott; Ken Grabstein; Christine Posavad; Lawrence Corey
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.

Authors:  Brian S Sheridan; Thomas L Cherpes; Julie Urban; Pawel Kalinski; Robert L Hendricks
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model.

Authors:  Magdalini Moutaftsi; Shahram Salek-Ardakani; Michael Croft; Bjoern Peters; John Sidney; Howard Grey; Alessandro Sette
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

7.  Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Authors:  Adan Chari Jirmo; Claus-Henning Nagel; Christof Bohnen; Beate Sodeik; Georg M N Behrens
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.

Authors:  Maya F Kotturi; Iain Scott; Tom Wolfe; Bjoern Peters; John Sidney; Hilde Cheroutre; Matthias G von Herrath; Michael J Buchmeier; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

10.  Effects of herpes simplex virus amplicon transduction on murine dendritic cells.

Authors:  Yahui Grace Chiu; William J Bowers; Seung T Lim; Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

View more
  66 in total

1.  Clonal expansions of CD8⁺ T cells in latently HSV-1-infected human trigeminal ganglia.

Authors:  Kathrin Held; Ingrid Eiglmeier; Susanne Himmelein; Inga Sinicina; Thomas Brandt; Diethilde Theil; Klaus Dornmair; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-14       Impact factor: 2.643

Review 2.  CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.

Authors:  Anthony J St Leger; Robert L Hendricks
Journal:  J Neurovirol       Date:  2011-12-08       Impact factor: 2.643

Review 3.  Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.

Authors:  K J Laing; L Dong; J Sidney; A Sette; D M Koelle
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

4.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

5.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

6.  PD-L1/B7-H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia.

Authors:  Sohyun Jeon; Anthony J St Leger; Thomas L Cherpes; Brian S Sheridan; Robert L Hendricks
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

7.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

8.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

9.  Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Elizabeth Kritzer; Sravya Chilukuri; Sumit Garg; David C Yu; Hawa Vahed; Lei Huang; Sabrina A Syed; Julie N Furness; Tien T Tran; Nesburn B Anthony; Christine E McLaren; John Sidney; Alessandro Sette; Randolph J Noelle; Lbachir BenMohamed
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

10.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.